Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nagourney Cancer Institute logo — company profile

Nagourney Cancer Institute

Founded 1995 9 employees Biotechnology, Health Care +1

General Information

Company Name Nagourney Cancer Institute
Founded Year 1995
Employees 9
Industries Biotechnology, Health Care, Pharmaceutical
Social

Get notified when Nagourney Cancer Institute moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Nagourney Cancer Institute

Nagourney Cancer Institute was founded in 1995 by Dr. Robert Nagourney. The institute has developed the Ex Vivo Analysis of Programmed Cell Death (EVA-PCD) assay, a state-of-the-art functional profiling test that produces a functional/phenotypic profile of a patient’s cancer. This analysis, based on tumor biology, identifies in real-time which therapies induce the cancer cells to shut down and die, helping patients and their doctors choose the most effective, least toxic treatment. The EVA-PCD analysis has shown to double response rates and increase survival. The institute also provides services to pharmaceutical companies by determining the efficacy of new drugs in a variety of human tumor diagnoses. Nagourney Cancer Institute accepts samples from around the world and provides timely results for most types of cancers. Dr. Nagourney, who is available for clinical consultations, owns and operates the institute. He is a frequently invited speaker, an active blogger, and the author of the book Outliving Cancer. The institute has been featured on national and local television and in major newspapers. For specific cases, patients can contact the Patient Relations Representatives at 1-800-542-4357. Nagourney Cancer Institute stands as the only cancer testing laboratory with an onsite practicing hematologist/oncologist. The institute operates within the Biotechnology, Health Care, and Pharmaceutical industries.

No funding data available for Nagourney Cancer Institute yet.

Get notified when Nagourney Cancer Institute raises funding

Nagourney Cancer Institute Alternatives & Competitors

Nagourney Cancer Institute vs
Biocept, Inc.
Biocept, Inc. United States

Helping physicians improve outcomes for metastatic cancer patients by delivering advanced diagnostic...

Post Ipo Equity
49 employees
Biotechnology, Health Care
Nagourney Cancer Institute vs
Kiyatec Inc.
Kiyatec Inc. United States

Changing the future of cancer care by accurately predicting patient response to therapies before tre...

Unknown
16 employees
Biotechnology, Health Care
Nagourney Cancer Institute vs
PrognosDx Health
PrognosDx Health United States

Pioneering the future of cancer diagnostics through advanced epigenetic testing and innovative histo...

Debt Financing
2-10 employees
Biotechnology, Health Care

FAQ About Nagourney Cancer Institute

With 20+ years of research, Dr. Nagourney has developed the Ex Vivo Analysis of Programmed Cell Death (EVA-PCD) assay which is a state-of-the-art functional profiling test that produces a functional/phenotypic profile of a patient’s cancer. This analysis is based on tumor biology and identifies in...
Nagourney Cancer Institute was founded in 1995.
Nagourney Cancer Institute operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Nagourney Cancer Institute has approximately 9 employees.
Top alternatives and competitors to Nagourney Cancer Institute include Biocept, Inc. , Kiyatec Inc., PrognosDx Health, Biolidics Limited (Formerly known as Clearbridge BioMedics), NUTEK- Insight beyond the visible. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nagourney Cancer Institute and Biocept, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Nagourney Cancer Institute and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes